Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxacon in Knee Arthrosis
NCT05925725Phase 4Completed
- Sponsor
- Ospedale Fatebenefratelli
- Start
- Jan 2023
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (3 arms), sponsored by Ospedale Fatebenefratelli. Primary endpoints: Western Ontario and McMaster Universities Arthritis Index at 1 year, Visual Analogue Scale at 1 year and 2 more. Started Jan 2023; status: completed.
Beyond the preview
Go deeper on NCT05925725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05925725.